Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. GLUCANTIME (méglumine (antimoniate de))
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

GLUCANTIME (méglumine (antimoniate de))

Medicine - Posted on Nov 07 2016 - Updated on Jun 12 2019
Active substance (DCI)
  • méglumine (antimoniate de)
history (3)
  • 10/19/16

    GLUCANTIME (méglumine (antimoniate de))

    Maintien du remboursement dans les mêmes conditions
    icône flèche
  • 9/7/11

    GLUCANTIME (méglumine (antimoniate de))

    GLUCANTIME (méglumine (antimoniate de))
    icône flèche
  • 11/8/06

    GLUCANTIME (méglumine (antimoniate de))

    GLUCANTIME (méglumine (antimoniate de))
    icône flèche
Technical information
ATC code
  • P01CB01
Manufacturer
SANOFI-AVENTIS FRANCE
Presentation

GLUCANTIME 1,5 g/5 ml, solution injectable (code CIS : 60576634) 5 ampoule(s) en verre de 5 ml - Code CIP : 3400932726677

All our publications
    Digestive system diseases - miscellaneous Drug therapy Parasitic diseases and mycoses Skin and connective tissue diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
DjcGQQvkRS4sSgFW